Loading

Please wait...

Oncaspar

Generic Name: pegaspargase (peg ah SPAR jase)
Brand Name: Oncaspar
Physician reviewed Oncaspar patient information - includes Oncaspar description, dosage and directions.
  • Prescription Settings

Prices and coupons of Oncaspar

Current Location: 20149 (Ashburn)
Change Location?

Enter your zip code


Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Oncaspar is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Oncaspar is used in combination with other cancer medications to treat acute lymphoblastic leukemia. Oncaspar is also used to treat allergic reactions to another cancer medication called asparaginase (Elspar). Oncaspar may also be used for purposes not listed in this medication guide. You should not use Oncaspar if you have ever received asparaginase and it caused pancreatitis, severe bleeding, a blood clot, or a severe allergic reaction. Learn more

Oncaspar Side Effects

Oncaspar Side Effects

Note: This document contains side effect information about pegaspargase. Some of the dosage forms listed on this page may not apply to the brand name Oncaspar.

For the Consumer

Applies to pegaspargase: parenteral injection

Side effects include:

Hypersensitivity reactions, coagulopathy, hyperglycemia, elevated serum transaminase concentrations, hyperbilirubinemia, pancreatitis, CNS thrombosis. No apparent difference in adverse effects following IV versus IM administration.

For Healthcare Professionals

Applies to pegaspargase: injectable solution

General

The most commonly reported side effects were elevated transaminases and clinical allergic reactions to asparaginase (including bronchospasm, hypotension, laryngeal edema, local erythema or swelling, systemic rash, and urticaria).

Hypersensitivity

Very common (10% or more): Hypersensitivity, urticaria, anaphylactic reaction

Nervous system

Common (1% to 10%): Central nervous system thrombosis/hemorrhage, seizure, peripheral motor neuropathy, syncope

Rare (less than 0.1%): Posterior reversible leukoencephalopathy syndrome

Frequency not reported: Somnolence, tremor

Cardiovascular

Common (1% to 10%): Thrombosis, embolism

Gastrointestinal

Very common (10% or more): Pancreatitis, diarrhea, abdominal pain, nausea

Common (1% to 10%): Vomiting, stomatitis, ascites

Rare (less than 0.1%): Pancreatitis necrotizing, pancreatitis hemorrhagic

Frequency not reported: Pancreatic pseudocyst, parotitis

Hematologic

Very common (10% or more): Febrile neutropenia

Common (1% to 10%): Coagulopathy (prolonged prothrombin time or partial thromboplastin time; or hypofibrinogenemia), anemia

Frequency not reported: Bone marrow failure

Hepatic

Very common (10% or more): Elevated transaminases

Common (1% to 10%): Hyperbilirubinemia, hepatotoxicity, fatty liver

Rare (0.01% to 0.1%): Hepatic necrosis, jaundice, cholestasis, hepatic failure

Metabolic

Common (1% to 10%): Hyperglycemia, weight decreased, decreased appetite

Frequency not reported: Glucose intolerance, hyperlipidemia, hypercholesterolemia, diabetic ketoacidosis, hypoglycemia

Immunologic

Common (1% to 10%): Infections, sepsis

Musculoskeletal

Common (1% to 10%): Pain in extremities

Psychiatric

Frequency not reported: Confusion

Respiratory

Common (1% to 10%): Hypoxia

Other

Frequency not reported: Pyrexia

Renal

Frequency not reported: Acute renal failure

Dermatologic

Very common (10% or more): Rash

Frequency not reported: Toxic epidermal necrolysis (TEN), cerebrovascular accident, hemorrhage, superior sagittal sinus thrombosis

Editorial References and Review

Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.

Source: Drugs.com Oncaspar